Demonstrates improved fucoxanthin production in Poterioochromonas malhamensis, suggesting a new commercial pathway.
Fucoxanthin is a highly commercially valuable carotenoid derived from algae. The golden microalga Poterioochromonas malhamensis shows promise as a source of fucoxanthin, but the commercial viability is hindered by its low fucoxanthin content and productivity. This study introduces a novel heterotrophic-photomixotrophic approach in which P. malhamensis was initially cultivated heterotrophically and then shifted to photomixotrophic culture conditions. This process achieved a remarkable fucoxanthin content of 1.58 % and a productivity rate of 12.4 mg L −1 d −1 , representing a 10-fold increase in content and a 2-fold increase in productivity compared to previous studies. Transcriptome analysis revealed preliminary mechanisms driving these improvements, including enhanced precursor supply, regulation of transcription factors, and catabolism of β-1, 3-glucans. Furthermore, techno-economic analysis indicates that this novel approach presents a competitive advantage over existing fucoxanthin production systems based on diatom Phaeodactylum tricornutum . This work provides an innovative and commercially promising pathway for the scalable production of fucoxanthin.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: